Clinical trial
Combination Chemotherapy and Oblimersen in Treating Patients With Advanced…
NCT00055822 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00055822 |
|---|---|
| Title | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer |
| Official title | A Phase I/II Study of Oblimersen Sodium (G3139, Genasense) in Combination With Oxaliplatin, 5FU and Leucovorin (FOLFOX4) Regimen in Advanced Colorectal Cancer |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | oblimersen sodium, fluorouracil, leucovorin calcium, oxaliplatin |
| Enrollment | 16 |
| Start date | Oct 1, 2002 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Mar 7, 2003 |
| Last update posted | Jul 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: